Glaukos (GKOS) Price Target Raised to $175 on iDose Outlook
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowStifel has increased the price target for Glaukos (GKOS) to $175, reflecting a positive outlook for its iDose product. The adjustment suggests confidence in the product's market potential and could enhance investor sentiment. This revised target highlights Stifel's belief in growth prospects for Glaukos amid current market conditions. Such an increase may impact trading volumes and investor interest in Glaukos stock.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Alphabet (GOOGL) Shares Fall After Q2 Earnings Report
Oct 19
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
S&P 500 and Nasdaq Rise as AI Stocks Rebound Before Earnings
Oct 19